2024
Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapies Linked to Insurance Delays, Intravenous Infusions, and Lack of Pharmacy Support
Gottesman S, Xiao K, Nguyen H, Hernandez E, Saweris E, Jagannathan P, Jafri F, Davis J, Tong K, Tang Z, Gaidos J, Feagins L. Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapies Linked to Insurance Delays, Intravenous Infusions, and Lack of Pharmacy Support. Clinical And Translational Gastroenterology 2024, 16: e00808. PMID: 39718220, PMCID: PMC11932631, DOI: 10.14309/ctg.0000000000000808.Peer-Reviewed Original ResearchConceptsAdvanced therapiesRisk factorsMulticenter studyMulticenter study of patientsInflammatory bowel disease therapyStudy of patientsAdult inflammatory bowel diseasePatient-related factorsIntravenous drug deliverySmall molecule therapiesLogistic regression analysisInflammatory bowel diseaseBaseline demographicsDisease activityIntravenous infusionMolecule therapiesDisease characteristicsGastroenterology practiceTherapyBowel diseaseInsurance denialPatientsDoseIntravenous inductionCare team
2021
Disparities in Telehealth Utilization Within Pediatric Gastroenterology
Puthenpura V, Du N, Hauptman L, Porto AF. Disparities in Telehealth Utilization Within Pediatric Gastroenterology. Journal Of Pediatric Gastroenterology And Nutrition 2021, 73: 217-222. PMID: 34016884, DOI: 10.1097/mpg.0000000000003167.Peer-Reviewed Original ResearchConceptsPediatric gastroenterology practiceSignificant decreased oddsMultivariate logistic regressionDecreased oddsTelephone visitsGastroenterology practicePediatric GastroenterologyVideo visitsLogistic regressionDistressed Communities IndexAmbulatory care visitsAdjusted odds ratioConfidence intervalsUse of telemedicineNon-Hispanic whitesRace/ethnicityCare visitsClinic visitsRetrospective studyOdds ratioTelehealth utilizationPublic insurancePrivate insuranceTelemedicine programVisits
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply